Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia

REFERENCES

• Rozman, C. and Montserrat, E. (1995) "Chronic lympho-cytic leukemia", New England Journal of Medicine, 333, 1052— 1057.
   Google Scholar
• Zwiebel, J.A. and Cheson, B.D. (1998) "Chronic lympho-cytic leukemia: staging and prognostic factors", Seminars in Oncology, 25, 42–59.
   Google Scholar
• Chiorazzi, N. and Ferrarini, M. (2003) "B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor", Annual Review in Immunology, 21, 841–894.
   Google Scholar
• Orchard, J.A., Ibbotson, R.E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P.W., et al. (2004) "ZAP-70 expression and prognosis in chronic lymphocytic leukaemia", Lancet, 363, 105–111.
   Google Scholar
• Sarfati, M., Bron, D., Lagneaux, L., Fonteyn, C., Frost, H. and Delespesse, G. (1988) "Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia", Blood, 71, 94— 98.
   Google Scholar
• Lowe, J., Brown, B., Hardie, D., Richardson, P. and Ling, N. (1989) "Soluble forms of CD21 and CD23 antigens in the serum in B cell chronic lymphocytic leukaemia", Immunology Letters, 20, 103–109.
   Google Scholar
• Reinisch, W., Willheim, M., Hilgarth, M., Gasche, C., Mader, R., Szepfalusi, S., et al. (1994) "Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia", Journal of Clinical Oncology, 12, 2146–2152.
   Google Scholar
• Molica, S., Levato, D., Dell'Olio, M., Matera, R., Minervini,M., Dattilo, A., et al. (1996) "Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis", Haematologica, 81, 428–433.
   Google Scholar
• Sarfati, M., Chevret, S., Chastang, C., Biron, G., Stryck-mans, P., Delespesse, G., et al. (1996) "Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia", Blood, 88, 4259–4264.
   Google Scholar
• Knauf, W.U., Langenmayer, I., Ehlers, B., Mohr, B., Adorf,D., Nerl, C.H., et al. (1997) "Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia", Leukemia and Lymphoma, 27, 523–532.
   Google Scholar
• Leotard, S., Chastang, C., Travade, P., Jaudon, Tournilhac, 0., Baudet, S., et al. (2000) "Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia", The Hematology Journal, 1, 301–306.
   Google Scholar
• Lesesve, J.F., Florence, A.M., Maynadie, G.M. and Feugier, P. (2001) "Prognostic relevance of soluble CD23 levels in CLL", The Hematology Journal, 2, 355.
   Google Scholar
• DiRaimondo, F., Albitar, M., Huh, Y., O'Brien, S., Montillo, M., Tedeschi, A., et al. (2002) "The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease", Cancer, 94, 1721–1730.
   Google Scholar
• Molica, S., Levato, D., Cascavilla, N., Levato, L. and Musto, P. (1999) "Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-micro-globulin in B-cell chronic lymphocytic leukemia", European Journal of Haematology, 62, 117–122.
   Google Scholar
• Dighiero, G. (2002) "Is chronic lymphocytic leukemia one disease?", Haematologica, 87, 1233–1235.
   Google Scholar
• Delespesse, G., Suter, U., Mossalayi, D., Bettler, B., Sarfati, M., Hofstetter, H., et al. (1991) "Expression, structure, and function of the CD23 antigen", Advances in Immunology, 49, 149–191.
   Google Scholar
• Mossalayi, M.D., Arock, M. and Debre, P. (1997) "CD23/ Fc epsilon RII: signaling and clinical implication", Interna-tional Reviews in Immunology, 16, 129–146.
   Google Scholar
• Sarfati, M., Fournier, S., Christoffersen, M. and Biron, G. (1990) "Expression of CD23 antigen and its regulation by IL-4 in chronic lymphocytic leukemia", Leukemia Research, 14, 47–55.
   Google Scholar
• Barnett, D. and Reilly, J.T. (1989) "Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL", British Journal of Haematology, 73, 572.
   Google Scholar
• Dadmarz, R. and Cawley, J.C. (1988) "Heterogeneity of CLL: high CD23 antigen and alpha IFN receptor expression are features of favourable disease and of cell activation", British Journal of Haematology, 68, 279— 282.
   Google Scholar
• Schwarzmeier, J.D., Shehata, M., Hilgarth, M., Marschitz,I., Louda, N., Hubmann, R., et al. (2002) "The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia", Leukemia and Lympho-ma, 43, 549 — 554.
   Google Scholar
• Heintel, D., Schwarzinger, I., Chizzali-Bonfadin, C., Thal-hammer, R., Schwarzmeier, J., Fritzer-Szekeres, M., et al. (2001) "Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemia", Leukemia and Lymphoma, 42, 1315–1321.
   Google Scholar
• Lampert, IA., Wotherspoon, A., Van Noorden, S. and Hasserjian, R.P. (1999) "High expression of CD23 in the proliferation centers of chronic lymphocytic leukemia in lymph nodes and spleen", Human Pathology, 30, 648— 654.
   Google Scholar
• Lopez-Matas, M., Rodriguez-Justo, M., Morilla, R., Catovs-ky, D. and Matutes, E. (2000) "Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leuke-mia", Haematologica, 85, 1140–1145.
   Google Scholar
• Kintner, C. and Sugden, B. (1981) "Identification of antigenic determinants unique to the surfaces of cells transformed by Epstein-Barr virus", Nature, 294, 458–460.
   Google Scholar
• Thorley-Lawson, D.A., Nadler, L.M., Bhan, A.K. and Schooley, R.T. (1985) "BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus", Journal of Immunology, 134, 3007–3012.
   Google Scholar
• Kikutani, H., Suemura, M., Owaki, H., Nakamura, H., Sato, R., Yamasaki, K., et al. (1986) "Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching", Journal of Experi-mental Medicine, 164, 1455–1469.
   Google Scholar
• Waldschmidt, T.J., Conrad, D.H. and Lynch, RG. (1989) "Expression of B cell surface receptors. II. IL-4 can accelerate the developmental expression of the murine B cell IgE Fc receptor", Journal of Immunology, 143, 2820 — 2827.
   Google Scholar
• Kijimoto-Ochiai, S. (2002) "CD23 (the low-affinity IgE receptor) as a C-type lectin: a multidomain and multifunctional molecule", Cellular and Molecular Life Sciences, 59, 648— 664.
   Google Scholar
• Capron, M., Truong, M.J., Aldebert, D., Gruart, V., Suemura, M., Delespesse, G., et al. (1991) "Heterogeneous expression of CD23 epitopes by eosinophils from patients. Relationships with IgE-mediated functions", European Jour-nal of Immunology, 21, 2423–2429.
   Google Scholar
• Dugas, B., Paul-Eugene, N., Coqueret, 0., Mencia-Huerta, J.M. and Braquet, P. (1992) "Possible role of CD23 in allergic diseases", Research in Immunology, 143, 448–451.
   Google Scholar
• Kehry, M.R. and Yamashita, L.C. (1989) "Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing", Proceedings of the National Academy of Sciences of the United States of America, 86, 7556 — 7560.
   Google Scholar
• Karagiannis, S.N., Warrack, J.K., Jennings, K.H., Murdock, P.R., Christie, G., Moulder, K., et al. (2001) "Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells", Immunology, 103, 319–331.
   Google Scholar
• Aubry, J.P., Pochon, S., Graber, P., Jansen, KU. and Bonnefoy, J.Y. (1992) "CD21 is a ligand for CD23 and regulates IgE production", Nature, 358, 505–507.
   Google Scholar
• Bjorck, P., Elenstrom-Magnusson, C., Rosen, A., Severn-son, E. and Paulie, S. (1993) "CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes", European Journal of Immunology, 23, 1771 — 1775.
   Google Scholar
• Rao, M., Lee, W.T. and Conrad, D.H. (1987) "Character-ization of a monoclonal antibody directed against the murine B lymphocyte receptor for IgE", Journal of Immunology, 138, 1845 —1851.
   Google Scholar
• Lee, B.W., Simmons, C.-F.J., Wileman, T. and Geha, R.S. (1989) "Intracellular cleavage of newly synthesized low affinity Fc epsilon receptor (Fc epsilon R2) provides a second pathway for the generation of the 28-kDa soluble Fc epsilon R2 fragment", Journal of Immunology, 142, 1614 — 1620.
   Google Scholar
• Christie, G., Barton, A., Bolognese, B., Buckle, D.R., Cook, R.M., Hansbury, M.J., et al. (1997) "IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII)", European Journal of Immunology, 27, 3228–3235.
   Google Scholar
• Marolewski, A.E., Buckle, D.R., Christie, G., Eamshaw, D.L., Flamberg, P.L., Marshall, L.A., et al. (1998) "CD23 (FcepsilonRII) release from cell membranes is mediated by a membrane-bound metalloprotease", Biochemical Journal, 333, 573 — 579.
   Google Scholar
• Letellier, M., Sarfati, M. and Delespesse, G. (1989) "Mechanisms of formation of IgE-binding factors (soluble CD23) — I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights", Molecular Immunology, 26, 1105–1112.
   Google Scholar
• Gordon, J., Cairns, J.A., Liu, Y.J., Flores-Romo, L., MacLennan, IC., Jansen, KU., et al. (1991) "Role of membrane and soluble CD23 in lymphocyte physiology", Monographs in Allergy, 29, 156— 168.
   Google Scholar
• Delespesse, G., Sarfati, M., Wu, C.Y., Fournier, S. and Letellier, M. (1992) "The low-affinity receptor for IgE", Immunological Reviews, 125, 77–97.
   Google Scholar
• Wendel-Hansen, V., Riviere, M., Uno, M., jansson, I., Szpirer, J., Islam, M.Q., et al. (1990) "The gene encoding CD23 leukocyte antigen (FCE2) is located on human chromosome 19", Somatic Cell and Molecular Genetics, 16, 283–286.
   Google Scholar
• Yokota, A., Kikutani, H., Tanaka, T., Sato, R., Barsumian, E.L., Suemura, M., et al. (1988) "Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression", Cell, 55, 611 — 618.
   Google Scholar
• Fournier, S., Tran, I.D., Suter, U., Biron, G., Delespesse, G. and Sarfati, M. (1991) "The in vivo expression of type B CD23 mRNA in B-chronic lymphocytic leukemic cells is associated with an abnormally low CD23 upregulation by IL-4: comparison with their normal cellular counterparts", Leukemia Research, 15, 609–618.
   Google Scholar
• Alizadeh, A.A., Eisen, M.B., Davis, R.E., Ma, C., Lossos, IS., Rosenwald, A., et al. (2000) "Distinct types of diffuse large B-cell lymphoma identified by gene expression profil-ing", Nature, 403, 503 — 511.
   Google Scholar
• Hagen, M., Sacco, R.E., Sandor, M., Best, C., Nambu, M. and Lynch, R.G. (1995) "The Fc epsilon RII/CD23 gene is actively transcribed during all stages of murine B-lymphocyte development", Molecular Immunology, 32, 1245–1257.
   Google Scholar
• Goller, M.E., Kneitz, C., Mehringer, C., Muller, K., Jelley-Gibbs, D.M., Gosselin, E.J., et al. (2002) "Regulation of CD23 isoforms on B-chronic lymphocytic leukemia", Leu-kemia Research, 26, 795–802.
   Google Scholar
• Yokota, A., Yukawa, K., Yamamoto, A., Sugiyama, K., Suemura, M., Tashiro, Y., et al. (1992) "Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains", Proceedings of the National Academy of Sciences of the United States of America, 89, 5030–5034.
   Google Scholar
• Fournier, S., Yang, L.P., Delespesse, G., Rubio, M., Biron, G. and Sarfati, M. (1995) "The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia", British Journal of Haematology, 89, 373— 379.
   Google Scholar
• Fournier, S., Delespesse, G., Rubio, M., Biron, G. and Sarfati, M. (1992) "CD23 antigen regulation and signaling in chronic lymphocytic leukemia", Journal of Clinical Investiga-tion, 89, 1312–1321.
   Google Scholar
• Delespesse, G., Hofstetter, H., Sarfati, M., Suter, U., Nakajima, T., Frost, H., et al. (1989) "Human Fc epsilon Rh. Molecular, biological and clinical aspects", Chemical Immunology, 47, 79–105.
   Google Scholar
• Hubmann, R., Schwarzmeier, J.D., Shehata, M., Hilgarth,M., Duechler, M., Dettke, M., et al. (2002) "Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia", Blood, 99, 3742–3747.
   Google Scholar
• Ling, P.D., Hsieh, J.J., Ruf, I.K., Rawlins, D.R. and Hayward, S.D. (1994) "EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1", Journal of Virology, 68, 5375–5383.
   Google Scholar
• Zimber-Strobl, U., Strobl, L.J., Meitinger, C., Hinrichs, R., Sakai, T., Furukawa, T., et al. (1994) "Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hair-less", EMBO Journal, 13, 4973–4982.
   Google Scholar
• Henkel, T., Ling, P.D., Hayward, S.D. and Peterson, M.G. (1994) "Mediation of Epstein-Barr virus EBNA2 transacti-vation by recombination signal-binding protein J kappa", Science, 265, 92–95.
   Google Scholar
• Hsieh, J.J., Nofziger, D.E., Weinmaster, G. and Hayward, S.D. (1997) "Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation", Journal of Virology, 71, 1938–1945.
   Google Scholar
• Artavanis-Tsakonas, S., Rand, M.D. and Lake, R.J. (1999) "Notch signaling: cell fate control and signal integration in development", Science, 284, 770–776.
   Google Scholar
• Nickoloff, B.J., Osborne, B.A. and Miele, L. (2003) "Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents", Oncogene, 22, 6598— 6608.
   Google Scholar
• Bertrand, F.E., Eckfeldt, C.E., Lysholm, A.S. and LeBien, T.W. (2000) "Notch-1 and Notch-2 exhibit unique patterns of expression in human B-lineage cells", Leukemia, 14, 2095–2102.
   Google Scholar
• Ohishi, K, Varnum-Finney, B., Flowers, D., Anasetti, C., Myerson, D. and Bernstein, I.D. (2000) "Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1", Blood, 95, 2847–2854.
   Google Scholar
• Duechler, M., Schwarzmeier, J., Shehata, M., Hoelbl, A., Hilgarth, M. and Hubmann, R. (2004) "Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2", Leukemia in print.
   Google Scholar
• Witt, CM., Hurez, V., Swindle, CS., Hamada, Y. and Klug, C.A. (2003) "Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells", Molecular and Cell Biology, 23, 8637–8650.
   Google Scholar
• Witt, CM., Won, W.J., Hurez, V. and Klug, CA. (2003) "Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells", Journal of Immunology, 171, 2783–2788.
   Google Scholar
• Kuroda, K., Han, H., Tani, S., Tanigaki, K., Tun, T., Furukawa, T., et al. (2003) "Regulation of marginal zone B cell development by MINT, a suppressor of Notch/RBP-J signaling pathway", Immunity, 18, 301–312.
   Google Scholar
• Saito, T., Chiba, S., Ichikawa, M., Kunisato, A., Asai, T., Shimizu, K., et al. (2003) "Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development", Immunity, 18, 675–685.
   Google Scholar
• Tanigaki, K., Han, H., Yamamoto, N., Tashiro, K., Ikegawa, M., Kuroda, K., et al. (2002) "Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells", Nature Immunology, 3, 443–450.
   Google Scholar
• Hayakawa, K. and Hardy, R.R. (2000) "Development and function of B-1 cells", Current Opinion in Immunology, 12, 346— 353.
   Google Scholar
• Bikah, G., Carey, J., Ciallella, JR., Tarakhovsky, A. and Bondada, S. (1996) "CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells", Science, 274, 1906–1909.
   Google Scholar
• Murakami, M., Tsubata, T., Okamoto, M., Shimizu, A., Kumagai, S., Imura, H., et al. (1992) "Antigen-induced apoptotic death of Ly-1 B cells responsible for autoimmune disease in transgenic mice", Nature, 357, 77–80.
   Google Scholar
• Ellisen, L.W., Bird, J., West, D.C., Soreng, A.L., Reynolds, T.C., Smith, S.D., et al. (1991) "TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms", Cell, 66, 649–661.
   Google Scholar
• Radtke, F., Wilson, A., Mancini, S.J. and MacDonald, H.R. (2004) "Notch regulation of lymphocyte development and function", Nature Immunology, 5, 247–253.
   Google Scholar
• Girard, L., Hanna, Z., Beaulieu, N., Hoemann, C.D., Simard, C., Kozak, C.A., et al. (1996) "Frequent provirus insertional mutagenesis of Notchl in thymomas of MNITVD/ myc transgenic mice suggests a collaboration of c-myc and Notchl for oncogenesis", Genes & Development, 10, 1930 — 1944.
   Google Scholar
• Fitzgerald, K., Harrington, A. and Leder, P. (2000) "Ras pathway signals are required for notch-mediated oncogen-esis", Oncogene, 19, 4191–4198.
   Google Scholar
• Caligaris-Cappio, F. (1996) "B-chronic lymphocytic leuke-mia: a malignancy of anti-self B cells", Blood, 87, 2615–2620.
   Google Scholar
• Kuppers, R., Klein, U., Hansmann, M.L. and Rajewsky, K. (1999) "Cellular origin of human B-cell lymphomas", New England Journal of Medicine, 341, 1520 — 1529.
   Google Scholar
• Carsetti, R., Rosado, M.M. and Wardmann, H. (2004) "Peripheral development of B cells in mouse and man", Immunological Reviews, 197, 179 — 191.
   Google Scholar
• Stevenson, F.K. and Caligaris-Cappio, F. (2004) "Chronic lymphocytic leukemia: revelations from the B-cell receptor", Blood, 103, 4389 — 4395.
   Google Scholar
• Micchelli, C.A., Esler, W.P., Kimberly, W.T., Jack, C., Berezovska, 0., Kornilova, A., et al. (2003) "Gamma-secretase/presenilin inhibitors for Alzheimer's disease pheno-copy Notch mutations in Drosophila", FASEB Journal, 17, 79–81.
   Google Scholar
• Das, I., Craig, C., Funahashi, Y., Jung, K.M., Kim, T.W., Byers, R., et al. (2004) "Notch oncoproteins depend on gamma-secretase/presenilin activity for processing and func-tion", Journal of Biological Chemistry, 279, 30771 — 30780.
   Google Scholar